Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000;1998(2):CD001158.
doi: 10.1002/14651858.CD001158.

Moderate-term, low-dose corticosteroids for rheumatoid arthritis

L A Criswell  1 , K G Saag, K M Sems, V Welch, B Shea, G Wells, M E Suarez-Almazor
Affiliations

Moderate-term, low-dose corticosteroids for rheumatoid arthritis

L A Criswell et al. Cochrane Database Syst Rev. 2000.

Abstract

Objectives: To perform a systematic review of low-dose corticosteroid efficacy in the moderate term for the treatment of rheumatoid arthritis (RA).

Search strategy: We conducted a search in MEDLINE from 1966 to 1998, using the keywords "corticosteroids" and "rheumatoid arthritis". We also handsearched all issues of Arthritis and Rheumatism and the Scandinavian Journal of Rheumatology from their dates of first publication to 1994. Furthermore, we examined all Arthritis and Rheumatism abstracts over the 15 year period preceding 1994. References of all identified studies were searched for relevant trials. Authors of unpublished manuscripts were contacted.

Selection criteria: Studies were selected by two independent reviewers (LC, KS) using a set of predetermined criteria. Specifically, we required that trials be randomized or cross-over and report at least one of the following outcome measures in a quantitative manner: joint tenderness, joint swelling, grip strength, or erythrocyte sedimentation rate (ESR). We also required that trials be of at least three months duration and use prednisone (or a comparable corticosteroid preparation) at a mean dosage of less than or equal to 15 mg/day. We included studies that used either placebo or active drug controls (i.e., comparative studies).

Data collection and analysis: We compared the effectiveness of prednisone to placebo and/or active controls using a fixed effects model for continuous data. A chi square test for homogeneity was performed, and where heterogeneity existed a random effects model was used. We reported results for all available outcomes recommended by the Outcome Measures for Rheumatology Trials (OMERACT) group. These included the number of tender and swollen joints, pain, functional status and ESR. Grip strength was also evaluated. Standardized mean differences (SMD) were used for outcomes assessing the same concept with different scales (eg. swollen joint counts).

Main results: Very few studies directly assessed the effectiveness of corticosteroids for RA treatment and many were of poor methodologic quality. Only seven of 34 studies identified by our search met criteria for inclusion. Our results indicated that corticosteroids were significantly more effective than placebo controls for four of six outcomes assessed [standardized mean difference for tender joints = -0.37 (95%CI: -0. 59, -0.14), swollen joints = -0.41 (-0.67, -0.16), pain = -0.43 (-0. 74, -0.12), and functional status = -0.57 (-0.92, -0.22)]. The results for grip strength and ESR were not significant [GS = +0.30 (-0.19, +0.80), weighted mean difference (WMD) for ESR = -7.03 (-18. 06, +4.01)]. The single trial that compared prednisone to aspirin indicated no statistically significant difference between these groups for joint tenderness (0.10 (-0.35, +0.55) and for ESR [0.00 (-11.09, +11.09]. Overall, the four outcomes assessed in the single trial that compared prednisone to chloroquine suggested that the effectiveness of these two agents is similar [SMD for joint tenderness = +0.23 (-0.30, +0.75), swollen joints = +0.43 (-0.11, +0. 96), functional status = -0.27 (-0.80, +0.26), and WMD for ESR = -16. 00 (-30.58, -1.42)].

Reviewer's conclusions: Based on the limited data available, moderate-term prednisone treatment of RA appears to be superior to placebo and comparable to treatment with aspirin or chloroquine in improving several common rheumatoid arthritis disease activity measures.

PubMed Disclaimer

Conflict of interest statement

None known

References

References to studies included in this review

Empire 1995 {published data only}
    1. Empire Rheumatism Council Sub‐Committee. Multi‐Center controlled trial comparing cortisone acetate and acetyl salicylic acid in the long‐term treatment of rheumatoid arthritis. Ann Rheum Dis 1955;14:353‐363. - PMC - PubMed
Harris 1983 {published data only}
    1. Harris, E. D., Emkey, R.D., Nichols, J.E., and Newberg, A. Low dose prednisone therapy in rheumatoid arthritis: A double blind study. J Rheumatol 1983;10:713‐721. - PubMed
Kirwan 1995 {published data only}
    1. Kirwan, J. R., Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142‐6. - PubMed
Million 1984 {published data only}
    1. Million R, Poole P, Kellgren JH, Jayson MIV. Long‐term study management of rheumatoid arthritis. Lancet 1984;1(8381):812‐6. - PubMed
Stenberg 1992 {published data only}
    1. Stenberg, V. I., Fiechtner, J.J., Rice, J.R., Miller, D.R., Johnson, L.K. Endocrine control of inflammation: Rheumatoid arthritis double‐blind, crossover clinical trial. Int J Clin Pharm Res 1992;12:11‐18. - PubMed
Van Gestel 1995 {published data only}
    1. Van Gestel, A. M., Laan, RFJM, Haagsma, C.J., van de Putte, L.B.A., van Riel, P.L.C.M. Low‐dose oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold: a randomized double‐blind placebo‐controlled trial. Br J Rheumatol 1995;34:347‐51. - PubMed
Van Schaardenburg 95 {published data only}
    1. Van Schaardenburg, D. , Valkema, R., Dijkmans, B.A.C., Papapoulos, S., Zwinderman, A.H., Han, K.H., Pauwels, E.K.J., Breedveld, F.C. Prednisone for elderly‐onset rheumatoid arthritis: Outcome and bone mass in comparison to treatment with chloroquine. Arthritis Rheum 1995;38:334‐342. - PubMed

References to studies excluded from this review

Berntsen 1961 {published data only}
    1. Berntsen, C. A., Freyberg, R.H. Rheumatoid patients after five or more years of corticosteroid treatment: A comparative analysis of 183 cases. Ann Intern Med 1961;54:938‐953.
Boardmann 1967 {published data only}
    1. Boardmann, P. L., Hart F.D. Clinical measurement of the anti‐inflammatory effects of salicylates in rheumatoid arthritis. Br Med J 1967;4:264‐268. - PMC - PubMed
Buchanan 1988 {published data only}
    1. Buchanan, W. W., Stephen, L.J., and Buchanan, H.M. Are "homeopathic" doses of oral corticosteroids effective in rheumatoid arthritis?. Clin Exp Rheumatol 1988;6:281‐284. - PubMed
De Andrade 1964 {published data only}
    1. De Andrade, J. R., McCormick, N.N, and Hill, A.G.S. Small doses of prednisolone in the management of rheumatoid arthritis. Ann Rheum Dis 1964;23:158‐162. - PMC - PubMed
Deodhar 1973 {published data only}
    1. Deodhar, S. D., Dick, W.C., Hodgkinson, R., and Buchanan, W. Measurement of Clinical Response to anti‐inflammatory drug therapy in rheumatoid arthritis. Q J Med 1973;166:387‐401. - PubMed
Empire Cort 1957 {published data only}
    1. Empire Rheumatism Council Sub‐Committee. Multi‐Center controlled trial comparing cortisone acetate and acetyl salicylic acid in the long‐term treatment of rheumatoid arthritis. Ann Rheum Dis 1957;16:277‐289. - PMC - PubMed
Gray 1991 {published data only}
    1. Gray, R. , Doherty, S.M. Galloway, J., Coulton, L., De Broe, M., Kanis, J.A. A double‐blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis Rheum 1991;34:287‐295. - PubMed
Healy 1988 {published data only}
    1. Healy, L. A., and Sheets, P.K. The relation of polymyalgia rheumatica to rheumatoid arthritis. J Rheumatol 1988;15:750‐752. - PubMed
Hench 1949 {published data only}
    1. Hench, P. S., Kendall, E.C., Slocumb, C.C., and Polley, H.F. The effect of a hormone of the adrenal cortex 17‐hydroxy‐11‐dehydrocorticosterone: compound E and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Proc of Mayo Clinic 1949;8:181‐197. - PubMed
Joint ACTH 1954 {published data only}
    1. Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, ACTH, and Other Therapeutic Measures in Chronic Rheumatic Diseases. A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis. British Medical Journal 1954;1(4873):1223‐7. - PMC - PubMed
Joint ACTH cort 1957 {published data only}
    1. Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, ACTH, and Other Therapeutic Measures in Chronic Rheumatic Diseases. A comparison of cortisone and prednisone in treatment of rheumatoid arthritis. Br Med J 1957;2(5038):199‐202. - PMC - PubMed
Joint ACTH pred 1959 {published data only}
    1. Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, ACTH, and Other Therapeutic Measures in Chronic Rheumatic Diseases. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1959;18:173‐187. - PMC - PubMed
Joint ACTH pred 1960 {published data only}
    1. A Second Report by the Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, ACTH, and Other Therapeutic Measures in Chronic Rheumatic Diseases. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1960;19:331‐337. - PMC - PubMed
Joint ACTH2 1955 {published data only}
    1. Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of cortisone, ACTH, and other therapeutic measures in chronic rheumatic diseases. A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis: A second report. British Medical Journal 1955;2(4941):695‐700. - PMC - PubMed
Joint ACTH3 1957 {published data only}
    1. Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of cortisone, ACTH, and other therapeutic measures in chronic rheumatoid diseases. Long‐term results in early cases of rheumatoid arthritis treated with either cortisone or aspirin: a third report. British Medical Journal 1957;1(5023):847‐850. - PMC - PubMed
Lee 1973 {published data only}
    1. Lee, P. , Webb, J., Anderson, J., Buchanan, W.W. Method for assessing therapeutic potential of anti‐inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J 1973;2:685‐688. - PMC - PubMed
Lee 1976 {published data only}
    1. Lee, P. , Anderson, J.A., Miller J., Webb, J., Buchanan, W.W. Evaluation of analgesic action and efficacy of antirheumatic drugs. J Rheumatol 1976;3:283‐294. - PubMed
Lockie 1983 {published data only}
    1. Lockie, L. M., Gomez,E., and Smith, D.M. Low dose adrenocorticosteroids in the management of elderly patients with rheumatoid arthritis: Selected examples and summary of efficacy in the long‐term treatment of 97 patients. Semin Arthritis Rheum 1983;12:373‐381. - PubMed
McConkey 1973 {published data only}
    1. McConkey, B. , Crockson, R.A., Crockson, A.P., and Wilkinson, A.R. The effects of some anti‐inflammatory drugs on the acute‐phase proteins in rheumatoid arthritis. Q J Med 1973;168:785‐791. - PubMed
McConkey 1979 {published data only}
    1. McConkey, B. , Davies, P., Crockson, R.A., Crockson, A.P., Butler, M., Constable, T.J., Amos, R.S. Effects of gold, dapsone, and prednisone on serum C‐reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis 1979;38:141‐144. - PMC - PubMed
McDougall 1994 {published data only}
    1. McDougall, R. , Sibley, J.,Haga, M., and Russell, A. Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol 1994;21:1207‐1212. - PubMed
Messina 1992 {published data only}
    1. Messina, O. D., Barreira, J.C., Zanchetta, J.R., Maldonado‐Cocco, J.A., Bogado, C.E., Sebastian, O.N., Flores, D., Riopedre, A.M., Redondo, G., Lazaro, A. Effect of low doses of deflazacort vs. prednisone on bone mineral content in premenopausal rheumatoid arthritis. J Rheumatol 1992;19:1520‐1526. - PubMed
Myles 1976 {published data only}
    1. Myles, A. B., Schiller, L.F.G., Glass,D., and Daly, J.R. Single daily dose corticosteroid treatment. Ann Rheum Dis 1976;35:73‐76. - PMC - PubMed
Ritchie 1968 {published data only}
    1. Ritchie, D. M, Boyle, J.A., McInnes, J.M, Jasani, M.K., Dalakos, T., Grieveson, P., Buchanan, W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;147:393‐406. - PubMed
Tait 1994 {published data only}
    1. Tait, T. J., Le Gallez, P., Astbury, C., Bird, H.A. A clinical and biochemical evaluation of prednisolone in patients with active rheumatoid arthritis. Rheumatol Int 1994;13:241‐245. - PubMed
West 1967 {published data only}
    1. West, H. F. Rheumatoid arthritis: The relevance of clinical knowledge to research activities. Abstr World Med 1967;41:401‐417.
Zuckner 1969 {published data only}
    1. Zuckner, J. , Uddin, J., Ramsey, R.H. Adrenal‐pituitary relationships with prolonged low dosage steroid therapy in rheumatoid arthritis. Mo Med 1969;66:649‐658. - PubMed

Additional references

Arnett 1988
    1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 1988;31:315‐24. - PubMed
Borzak 1995
    1. Borzak S, Ridker PM. Discordance between meta‐analyses and large‐scale randomized, controlled trials. Annals of Internal Medicine 1995;123:873‐7. - PubMed
Byron 1986
    1. Byron MA, Kirwan JR. Corticosteroids in rheumatoid arthritis: Is a trial of their 'disease modifying' potential feasible?. Annals of the Rheumatic Diseases 1986;46:171‐3. - PMC - PubMed
Caldwell 1991
    1. Caldwell JR, Furst DE. The efficacy and safety of low‐dose corticosteroids for rheumatoid arthritis. Seminars in Arthritis and Rheumatism 1991;21:1‐11. - PubMed
Chalmers 1981
    1. Chalmers TC, Smith Jr. H, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A: A method for assessing the quality of a randomized control trial. Controlled Clin Trials 1981;2:31‐49. - PubMed
Chalmers 1987
    1. Chalmers TC, Levin H, Sacks HS, Reitman D, Berrier J, Nagalingam R: Meta‐analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co‐operative trials. Stat Med 1987;6:315‐325. - PubMed
Cohen 1988
    1. Cohen J. Statistical power analysis for the behavioral sciences. Second Edition. Hillsdale, New Jersey: Lawrence Erlbaum Associates, Inc., 1988.
Dickersin 1992
    1. Dickersin K, Berlin JA. Meta‐analysis: State‐of‐the‐science. Epidemiologic Reviews 1992;14:154‐76. - PubMed
Eberl 1976
    1. Eberl DR, Fasching V, Rahlfs V, Schleyer L, Wolf R. Repeatibility and objectivity of various measurements in rheumatoid arthritis. Arthritis and Rheumatism 1976;19:1278‐86. - PubMed
Felson 1990
    1. Felson DT, Anderson JJ, Meenan RF. The comparative efficacy, toxicity of second‐line drugs in rheumatoid arthritis. Arthritis and Rheumatism 1990;33:1449‐61. - PubMed
Felson 1992
    1. Felson D, Anderson JJ, Meenan RF. Use of short‐term efficacy/toxicity tradeoffs to select second‐line drugs in rheumatoid arthritis. Arthritis and Rheumatism 1992;35:1117‐25. - PubMed
Felson 1995
    1. Felson DT, Anderson JJ, Boers M, Bombarder C, Furst D, Goldsmith C, Katz LM, Lightfoot Jr. , R, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams HJ, Wolfe F, Kieszak S: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727‐735. - PubMed
Fries 1982
    1. Fries JG. The dimensions of health outcomes: The health assessment questionnaire. Journal of Rheumatology 1982;74:786‐93. - PubMed
Fries 1993
    1. Fries JG, Williams CA, Ramey D, Bloch DA. The relative toxicity of disease‐modifying antirheumatic drugs. Arthritis and Rheumatism 1993;36:297‐306. - PubMed
Gøtzsche 1992
    1. Gøtzsche PC, Pødenphant J, Olesen M, Halberg P. Meta‐analysis of second‐line antirheumatic drugs: Sample size bias and uncertain benefit. Journal of Clinical Epidemiology 1992;45:587‐94. - PubMed
Gøtzsche 1993
    1. Gøtzsche PC, Pødenphant J, Olesen M, Halberg P. Critique of meta‐analysis of second‐line antirheumatic drugs (Comment to the Editor). Journal of Clinical Epidemiology 1993;45:315‐21.
Gøtzsche 1998
    1. Gøtzsche PC, Johansen HK. Meta‐analysis of short‐term low dose prednisolone versus placebo and non‐steroidal anti‐inflammatory drugs in rheumatoid arthritis. BMJ 1998;316:811‐8. - PMC - PubMed
Hassell 1993
    1. Hassell AB, Davis MJ, Fowler PD, Clarke S, Fisher J, Shadforth MF, Jones PW, Dawes PT. The relationship between serial measures of disease activity and outcome in rheumatoid arthritis. Quarterly Journal of Medicine 1993;86:601‐7. - PubMed
Hedges 1982
    1. Hedges LV, Olkin I. Statistical methods for meta‐analysis. San Diego, California: Academic Press, 1982.
Iannuzzi 1983
    1. Iannuzzi L, Dawson N, Zein N, Kushner I. Does drug therapy slow radiographic deterioration in rheumatoid arthritis. New England Journal of Medicine 1983;309:1023‐27. - PubMed
Jadad 1996
    1. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1‐12. - PubMed
Kushner 1989
    1. Kushner I. Does aggressive therapy of rheumatoid arthritis affect outcome? (editorial). Journal of Rheumatology 1989;16:1‐4. - PubMed
Mann 1990
    1. Mann C. Meta‐analysis in the breech. Science 1990;249:476‐80. - PubMed
Meenan 1982
    1. Meenan RF, Gertman PM, Mason JH, Dunaif R. The arthritis impact measurement scales: Further investigations of a health status measure. Arthritis and Rheumatism 1982;25:1048‐53. - PubMed
Michel 1991
    1. Michel BA, Block DA, Fries JF. Predictors of fractures in early rheumatoid arthritis. Journal of Rheumatology 1991;18:804‐8. - PubMed
Naylor 1989
    1. Naylor CD. Meta‐analysis of controlled clinical trials (editorial). Journal of Rheumatology 1989;16:424‐6. - PubMed
Nettleman 1992
    1. Nettleman MD. Decision analysis and meta‐analysis: Dealing with information overload. In: Wenzel RP editor(s). Assessing Quality Health Care: Perspectives for clinicians. First Edition. Baltimore: Lippincott Williams & Wilkins, 1992:85‐100.
OMERACT 1993
    1. OMERACT. Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials. J Rheumatol 1993;20:526‐91. - PubMed
Petiti 1994
    1. Petiti DB. Meta‐analysis, decision analysis, and cost‐effectiveness analysis: Methods for quantitative synthesis in medicine. New York: Oxford University Press, 1994.
Pincus 1992
    1. Pincus T, Marcum SB, Callahan LF. Long term drug therapy for rheumatoid arthritis in seven rheumatology private practices: Second line drugs and prednisone. Journal of Rheumatology 1992;19:1885‐94. - PubMed
Pincus 1995
    1. Pincus T, Brooks RH, Stein CM: Changing patterns of patient care in rheumatoid arthritis: Use of methotrexate or prednisone in > 80% (both in 57%) of patients and frequent combination therapy with minimal evidence of disease in 36% of patients (abstract). Arthritis Rheum 1995;38:S366.
Ramos‐Remus 1992
    1. Ramos‐Remus C, Sibley J, Russell A. Steroids in Rheumatoid Arthritis: The honeymoon revisited (editorial). Journal of Rheumatology 1992;19:667‐70. - PubMed
Ropes 1958
    1. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bulletin on the Rheumatic Diseases 1958;9:175‐6. - PubMed
Saag 1994
    1. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, et al. Low dose long‐term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events. American Journal of Medicine 1994;96:115‐23. - PubMed
Saag 1996
    1. Saag KG, Kolluri S, Koehnke RK, Georgou TA, Hunninghake GW, Schwartz DA. Rheumatoid arthritis lung disease: Determinants of physiologic and radiographic abnormalities. Arthritis and Rheumatism 1996;39:1711‐9. - PubMed
Weisman 1993
    1. Weisman M. H: Should steroids be used in the management of rheumatoid arthritis?. Rheum Dis Clin North Am 1983;19:1:189‐199. - PubMed
Weiss 1989
    1. Weiss MM. Corticosteroids in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 1989;19:9‐21. - PubMed
Wolfe 1995
    1. Wolfe F, Furst D, Lane N, Anderson J, Hawley DJ. Substantial increases in important adverse events follow low dose prednisone therapy of rheumatoid arthritis (RA). Arthritis and Rheumatism 1995;38:S312.
Yelin 1995
    1. Yelin E, Callahan LF. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis and Rheumatism 1995;38:1351‐62. - PubMed

Publication types

MeSH terms

Substances